A well-known brand of veterinary drugs and poultry medicines, a comprehensive enterprise integrating R&D/production/sales/technical services/investment and import and export trade of veterinary biological products and diagnostic reagents, and its major animal disease vaccine industry is more famous
Qianyuanhao Biological Co., Ltd. (hereinafter referred to as "Qianyuanhao") is a large state-owned central enterprise, which was officially registered in the State Administration for Industry and Commerce on July 1, 2004, with a registered capital of 128 million yuan. Qianyuanhao is mainly engaged in the production, sales, research and development, technical services, project investment and import and export trade of veterinary biological products and diagnostic reagents.
Qianyuanhao is an enterprise designated by the Ministry of Agriculture to produce vaccines for major animal diseases such as highly pathogenic avian influenza, highly pathogenic porcine blue ear disease, swine fever and rabies, and has made outstanding contributions to the national prevention and control of avian influenza, foot-and-mouth disease and other major animal diseases. It has three GMP production bases with international advanced technology level - Nanjing Biopharmaceutical Factory, Zhengzhou Biopharmaceutical Factory, Beijing Biopharmaceutical Factory, and has a stake in Nanjing Merial Animal Health Co., Ltd. Nanjing Biopharmaceutical Factory can be traced back to 1931 and is the first manufacturer of veterinary biological products in China. Founded in 1949, Zhengzhou Biopharmaceutical Factory is the first in China to realize the industrial production of avian influenza vaccine. Founded in 1988, Beijing Biopharmaceutical Factory is one of the "Top Ten Innovative Enterprises" in Zhongguancun High-tech Park. Nanjing Meliá Animal Health Co., Ltd. is a high-tech joint venture jointly invested by the French Merial Group and Qianyuanhao, with 6 world-advanced and domestic leading production technologies.
At present, Qianyuanhao can produce nearly 60 varieties of veterinary biological products and diagnostic reagents, more than 200 specifications, with an annual output of more than 20 billion animal vaccines. The domestic market share of the products ranks in the forefront of the industry. The company's products have been exported to Indonesia, Egypt, Vietnam, Mongolia and other countries, and have established economic and trade cooperation relations with Africa, Southeast Asia and neighboring countries.
Qianyuanhao is a high-tech enterprise in Beijing, a well-known brand in Beijing, a tax credit A-level enterprise in Beijing, and an AAA credit enterprise in the Agricultural Bank of China, which has won more than 20 national, provincial and ministerial science and technology awards, and has strong scientific research and development strength.
Qianyuanhao is committed to becoming a professional poultry seedling company, and strives to build a world-renowned animal protection enterprise and a century-old store with an evergreen foundation.
